by Gabriel Levitt, President, PharmacyChecker.com and Prescription Justice | Nov 16, 2011 | Advocacy, Online Pharmacies
The “Stop Online Piracy Act” (SOPA), currently before Congress, threatens online access to safe and affordable medication through reputable international online pharmacies. A CBS-Fort Myers report gives a human face to this issue by highlighting a Floridian senior, Mary Miller, who is able to afford her medication only because of a Canadian online pharmacy. If SOPA passes, Ms. Miller may lose access to that Canadian online pharmacy. The CBS report features RxRights.org as the lead organization helping Americans rally to contact their elected officials to oppose SOPA.
Stopping rogue sites in many areas, such as those sites that steal and re-sell copyrighted movies and music, sell knockoffs of designer handbags and clothes, and especially those that sell dangerous or fake medication is the right idea. But a bill that could takedown many websites that are exercising the rights of free speech, publishing music and movies legally, and especially websites selling safe and affordable medication, is a bill that should be abandoned post-haste.
RxRights.org should be loudly applauded for its work on behalf of Americans who are struggling to afford medication by educating Americans about SOPA and how it could block access to affordable prescription medication.
Tagged with: affordability, Canada, Canadian pharmacies, CBS, Congress, copyright, Florida, Online Pharmacies, rogue sites, RxRights.org, safety, SOPA, Stop Online Piracy Act
by PharmacyChecker.com | Nov 15, 2011 | Drug Prices, Generic drugs
Our last post highlighted the end-of-the-month release of the long-awaited generic version of Lipitor, the most popular cholesterol-lowering drug in America. Brand-name Lipitor, manufactured by drug giant Pfizer, has been one of the key contributors to American’s high drug bills for the past 15 years. A generic version will mean massive savings for some and basic affordability for many.
Last week, however, the New York Times shared that Pfizer (unsurprisingly) wants to block access to that affordable generic. Pfizer is going to offer “large discounts for benefit managers that block the use of generic versions of Lipitor” – “When patients submit a prescription for a generic version of Lipitor, they are to be given Lipitor instead.” So, those covered by the benefit managers who accept the discount will end up paying the same high co-pay, despite the availability of a lower priced drug!
These tactics by the largest drug manufacturer to keep drug prices higher are disappointing but not surprising. After all, in addition to lobbying the U.S. government to prevent safe personal drug importation, it funds programs to scare Americans away from buying its own medication at a lower price from Canada and other countries.
Pfizer’s latest move seems to only affect Americans with health insurance who, under the Pfizer/benefit manager deal, would pay $25 monthly co-pays (instead of $10 per month) – that’s $75 for a three month supply. That’s a stark contrast to Americans without health insurance who can pay $535.00 at a local CVS in New York City. By comparing prices of verified online pharmacies at PharmacyChecker.com, the uninsured may at least knock their monthly brand name Lipitor costs to $85.70.
Fortunately, due to the economics of generic drug competition, generic Lipitor prices will eventually offer great savings to the uninsured and we’ll be keeping you updated as those new products come to market.
Tagged with: brand-name, Cholesterol, co-pays, CVS, generic drugs, health insurance, insured, Lipitor, New York City, New York Times, PBM, Pfizer, pharmacy benefit managers, pharmacychecker.com, uninsured, United States
by Gabriel Levitt, Vice President, PharmacyChecker.com and Margaret Rode, PharmacyChecker.com | Nov 10, 2011 | Drug Prices, Generic drugs
As reported in the The Inquisitr, due to generic competition, Lipitor prices are going to plummet in the near future, a relief not only to American patients but to U.S. doctors who often find their patients not taking their cholesterol medication due to cost. In discussing his patients, Dr. Thomas Haffey stated in the article:
They often make tough decisions about whether they eat or whether they take the medicines… Any time you can reduce the costs of quality health care, we certainly are happy and encouraged about that.
High drug prices in the United States lead to 10s of millions of Americans not taking needed medication each year. The end of Pfizer’s patent on Lipitor means that Americans will now be able to more easily afford Atorvastatin – the generic name for Lipitor – in local U.S. pharmacies. As of the end of this month, according The Missourian, a three-month supply of generic Lipitor will cost $30. And the Inquisitr article suggests that within six months generic Lipitor will be priced at $5 for a one-month supply.
To maintain market share, Pfizer, the manufacturer of Lipitor, may come up with some competitive sales strategies. For instance, Pfizer may cut costs for insured Americans to only $4/month co-pays. Pfizer is also pushing to market an over-the-counter version of Lipitor, however it is not yet approved for sale.
According to our research, U.S. prices for a 90-day supply of Lipitor 20mg at a New York City CVS costs $535.99, compared to $85.70 at the lowest cost online pharmacy approved by PharmacyChecker.com – a savings of 84%. So if you want the brand name drug you may be better off with low-cost online pharmacies. But, come the end of November, the best prices for generic Lipitor will soon be available in the good old USA.
Tagged with: Atorvastatin, bricks and mortar, Cholesterol, co-pay, cost, coupon, CVS, generic, Lipitor, over-the-counter, patent, Pfizer, pharmacy, pharmacy checker.com, The Inquisitr, The Missourian, United States
by PharmacyChecker.com | Oct 31, 2011 | Drug Prices
While millions of Americans cannot afford brand name drugs in the United States, clearly this is not the case for generics – and the prices here keep getting lower! Marc’s, an Ohio-based retail pharmacy, has dropped prices for their generic drugs to a record breaking low – now charging just $1.98 for 30-day supplies of some of their generic drugs. Twenty-seven different generics are offered at this price.
Marc’s low-cost pricing comes as a response to their retail competition doing the same. In order to compete with chain store rivals like Target, Wal-mart and Kmart, smaller, local pharmacies are offering some of the lowest prices. Another example, Discount Drug Mart, – also in Ohio – dropped many of their generics to $1.99 for a month’s supply; this led Marc’s to sneak in at a penny less.
If you’re buying online, Costco.com has very low generic drug prices as well. You can compare prices on www.pharmacychecker.com.
Tagged with: Costco, Drug Prices, generic drugs, generics, Kmart, local, low-cost, Marc's, Ohio, Online Pharmacies, Target, United States, Wal-Mart
by Gabriel Levitt, President, PharmacyChecker.com and Prescription Justice | Oct 20, 2011 | Drug Prices
The simple answer is that tens of millions of Americans cannot afford prescription drugs here in the United States because they’re too expensive. Meanwhile, drug prices outside the U.S. are much lower – often 80% lower. Americans skipping or not taking prescription drugs is a national emergency largely going ignored in our healthcare debate.
Here are the facts about Americans skipping medication due to drug prices:
1. 25 million Americans did not take prescribed medication in 2009 due to cost, according to the U.S. Centers for Disease Control and Prevention. From 1997 to 2009, the percentage of Americans not taking their medications due to cost nearly doubled increasing from 4.8 to 8.4%.
Source: National Center for Health Statistics 2011. http://www.cdc.gov/nchs/data/hus/hus10.pdf#highlights
2. 48 million Americans ages 19-64 did not fill a prescription due to cost in 2010, according to the Commonwealth Fund – a 66% increase since 2001.
Source: The Commonwealth Fund 2010 Biennial Health Insurance Survey, http://www.commonwealthfund.org/Surveys/2011/Mar/2010-Biennial-Health-Insurance-Survey.aspx.
3. 3.4 million Medicare enrollees stop taking their medication due to the coverage gap.
Source: Polinski JM, Shrank WH, Huskamp HA, Glynn RJ, Liberman JN, et al. 2011 Changes in Drug Utilization during a Gap in Insurance Coverage: An Examination of the Medicare Part D Coverage Gap. PLoS Medicine.
4. Prescription non-adherence adds $290 billion to America’s healthcare costs.
Source: U.S. Food and Drug Administration. 76 FR 12969. March 2011. http://www.federalregister.gov/articles/2011/03/09/2011-5287/campaign-to-improve-poor-medication-adherence-u18.
Access our RxSOS fact sheet here.
Tagged with: Commonwealth Fund, coverage gap, Drug Prices, FDA, FDA warnings, healthcare, international pharmacies, Medicare, National Center for Health Statistics, PLoS, prescription non-adherence, prescriptions, Public Library of Science, safety, U.S. Centers for Disease Control and Prevention, U.S. Food and Drug Administration, United States
by PharmacyChecker.com | Oct 14, 2011 | Medicare Drug Plans
If you are eligible for Medicare Part D (Drug Plans), you should be aware that 1) open enrollment starts tomorrow, October 15th and 2) you can now research Medicare Part D plans on our site MedicareDrugPlans.com. On the site you find out which plans are rated best (or worst) by people enrolled in them. You’ll also get the 2011 pricing information for every plan in each U.S. state and territory. The information is completely objective – we are not affiliated with any plan.
If you are already enrolled in a Part D plan, MedicareDrugPlans.com allows you to rate and review your current plan, so others can learn from you.
To actually sign up for a plan, we recommend using the government’s website, Medicare.gov – at which you can best determine which plan covers all the prescription drugs you take. Comparing costs and features can be crucial to your health and your finances. Annual deductible, monthly premium and drug coverage (especially in the “doughnut hole”) are important to consider when choosing or changing your prescription plan.
This year the average premium nationally is $55, actual $1 lower than last year! The standard deductible, on the other hand, increased from $310 to $320. Less than ten plans offer coverage through the doughnut hole. However, under the new health care law, brand name drugs are now 50% off through this coverage gap period.
As open enrollment begins, Medicare enrollees interested in a drug plan are urged to research carefully. Whatever plan you choose will go into effect starting January 1st, 2011 and last for one full year – so get it right! Go to www.MedicareDrugPlans.com now.
Tagged with: deductible, doughnut hole, health care, Medicare, Medicare.gov, Open Enrollment, Part D, premium, prescription drug plans, ratings, United States
